Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prophylactic oophorectomy.

George Coukos1, Stephen C Rubin

  • 1Division of Gynecologic Oncology, University of Pennsylvania Medical Center, 1000 Courtyard, 3400 Spruce Street, Philadelphia, PA 19104, USA.

Best Practice & Research. Clinical Obstetrics & Gynaecology
|November 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combinatorial delivery of low-dose radiotherapy and immunotherapy to patients with immune-excluded tumors enhances CD8+ T cell functionality.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Cancer immunotherapy insights: key takeaways from the ADSCC bone marrow and cellular therapy congress 2024.

Frontiers in immunology·2026
Same author

Highly efficient gene knockout in tumor-infiltrating lymphocytes by adenine base editing.

Molecular therapy. Oncology·2025
Same author

The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

Journal for immunotherapy of cancer·2025
Same author

Multi-modal image analysis for large-scale cancer tissue studies within IMMUcan.

Cell reports methods·2025
Same author

Immune correlates and mechanisms of TIL therapy efficacy: current insights and knowledge gaps.

Trends in cancer·2025
Same journal

A risk-based classification of late-onset fetal growth disorders according to intrapartum fetal compromise.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

The Cardiac-Fetal-Placental Unit: links between umbilical venous flow and maternal hemodynamics in fetal growth restriction.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Psychosocial interventions for women who are pregnant following a previous reproductive loss: A scoping review.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Controversies in fetal therapy.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Alloimmunisation in pregnancy: current management and future perspectives.

Best practice & research. Clinical obstetrics & gynaecology·2026
Same journal

Consensus in prenatal management of Hemolytic disease of the fetus and newborn.

Best practice & research. Clinical obstetrics & gynaecology·2026
See all related articles

Prophylactic oophorectomy is a key strategy for reducing ovarian cancer risk, especially for those with hereditary predispositions. This procedure offers a significant benefit, potentially lowering cancer incidence in the general population.

Area of Science:

  • Oncology
  • Genetics
  • Preventive Medicine

Background:

  • Ovarian cancer prevention lacks effective alternatives, making prophylactic oophorectomy a primary strategy.
  • Hereditary ovarian cancer genetics significantly increase lifetime risk, necessitating risk-benefit assessments for surgical intervention.

Purpose of the Study:

  • To assess the risks and benefits of prophylactic oophorectomy for ovarian cancer prevention.
  • To evaluate the procedure's impact on individuals with hereditary genetic predispositions and the general population.

Main Methods:

  • Review of hereditary ovarian cancer genetics.
  • Risk-benefit analysis of prophylactic oophorectomy in specific patient populations.
  • Modeling the impact of routine salpingo-oophorectomy on general population incidence.

Related Experiment Videos

Main Results:

  • Prophylactic oophorectomy is the most effective available method for reducing individual ovarian cancer risk.
  • Patients with hereditary genetic predispositions face lifetime ovarian cancer risks ranging from 16-65%.
  • Routine salpingo-oophorectomy in women over 40 undergoing surgery could decrease overall ovarian cancer incidence by up to 5%.

Conclusions:

  • Prophylactic oophorectomy is recommended for individuals at high risk due to hereditary factors.
  • Routine salpingo-oophorectomy during other surgeries presents a viable population-level strategy for ovarian cancer reduction.